Table 1.
GD (n = 9) | LCKD (n = 9) | p-value | |
---|---|---|---|
Age(year) | 66.3 ± 9.8 | 58.3 ± 7.6 | 0.072 |
Sex(n(%)) | |||
Male | 6(66.7) | 5(55.6) | 1.000 |
Female | 3(33.3) | 4(44.4) | |
Histological type | |||
Pancreatic ca. | 2 | 3 | |
(head/body/tail) | (1/0/1) | (1/2/0) | |
Ampulla of Vater cancer | 2 | 1 | 0.741 |
Common bile duct | 5 | 3 | |
Duodenal cancer | 0 | 1 | |
NET | 0 | 1 | |
Surgical operation | |||
PPPD | 7 | 8 | 1.000 |
DP | 2 | 1 | |
BMI (kg/m2) | 22.2 ± 2.7 | 24.0 ± 2.2 | 0.149 |
Weight (kg) | 56.3 ± 7.3 | 63.1 ± 10.1 | 0.117 |
CEA | 2.13 ± 1.23 | 1.95 ± 0.63 | 0.693 |
CA19-9 | 150.6 ± 306.5 | 31.8 ± 33.9 | 0.265 |
Hospitalization period | 17.4 ± 11.8 | 11.3 ± 2.1 | 0.161 |
Total oral diet period (day) | 11.9 ± 10.5 | 7.5 ± 4.3 | 0.146 |
Percentage of energy intake to EER (kcal/kcal %)* | |||
from total caloric intake (%) | 87.5 ± 16.6 | 89.8 ± 22.4 | 0.807 |
from meal (%) | 31.9 ± 12.5 | 44.8 ± 18.4 | 0.101 |
from PN | 57.0 ± 21.1 | 45.9 ± 8.5 | 0.197 |
Values are mean ± standard deviation. p-values were derived from independent Student’s t-tests at baseline. The statistical differences between GD and LCKD groups for histological type were obtained using Fisher’s exact test after crossover analysis.
NET, neuroendocrine tumour; PPPD, pylorus-preserving pancreaticoduodenectomy; DP, distal pancreatectomy; BMI, body mass index; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9; EER, estimated energy requirement; PN, parenteral nutrition.